Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2009
08/26/2009CN100531783C Health-care food for reducing blood sugar on the assistant role and its preparing process
08/26/2009CN100531742C Antineoplastic super fine particle of amino-polysaccharide, and its preparing method
08/26/2009CN100531735C Novel technique of preparing lactic acid ciprofloxacin injection
08/26/2009CN100531734C Atracurium freezing-dried composition
08/26/2009CN100531733C Aqueous pharmaceutical solution containing oxymetazoline and/or xylometazoline
08/26/2009CN100531730C Nateglinide-containing hydrophilic pharmaceutical preparation
08/26/2009CN100531728C Use of neuron sodium ion pass antagonist for controlling homothermal animal ectoparasite
08/26/2009CN100531724C Film preparation for biphasic release of pharmacologically active or other substances
08/26/2009CN100531723C Calf serum protein-removing extract for injection and its preparation method
08/26/2009CN100531720C A long-circulating nanoliposome carrier of hydroxycamptothecine and preparation method thereof
08/26/2009CN100531719C Slow-released injection containing methotrexate synergist
08/26/2009CN100531718C Slow-released injection containing methotrexate synergist
08/26/2009CN100531717C Slow-released anticancer preparation containing methotrexate
08/26/2009CN100531716C Slow-released injection containing methotrexate and its synergist
08/26/2009CN100531715C Slow-released methotrexate injection
08/26/2009CN100531712C Dasatini sustained-release implants for treating entity tumor
08/26/2009CN100531711C Erlotinib sustained-release implants for treating entity tumor
08/26/2009CN100531710C Alendronate pharmaceutical composition and its preparation technique
08/25/2009USRE40882 High concentration of alpha, beta or gamma interferon in buffered solution with polyvinylpyrrolidone and/or polyethylene oxide, and antioxidant, Trilon B (disodium salt of ethylenediaminetetraacetic acid); bioavailability; topical administration to mucous membrane with prolonged contact; bioavailability
08/25/2009US7579377 Use of adapalene or salt thereof to treat skin disorders having an inflammatory or proliferative component such as acne or psoriasis; dosage forms
08/25/2009US7579324 Carrier, linker and nonantibiotic therapeutic agent; small molecules; bioavailability, efficacy
08/25/2009US7579322 Compositions and methods for promoting myocardial and peripheral angiogenesis
08/25/2009US7579173 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using the same
08/25/2009US7579015 improved average foam stability; surfactant, dimer acid, an (olefin) block copolymer, an oil or fat and water
08/25/2009US7579014 Mesoporous compositions for use in drug delivery
08/25/2009US7579013 Transdermal drug delivery device having stratum corneum-piercing microprojections; pH stability and solubility when dried;
08/25/2009US7579010 Botulinum toxin pharmaceutical compositions with a recombinant human serum albumin
08/25/2009US7578809 Surface modified viscoelastics for ocular surgery
08/25/2009CA2634663C Novel albumin-free factor viii formulations
08/25/2009CA2426680C Process for formulation of antibiotic compounds
08/25/2009CA2395539C Soluble interleukin-20 receptor
08/25/2009CA2394794C Methods for preparing pharmaceutical formulations
08/25/2009CA2368356C Patches containing buprenorphine hydrochloride
08/25/2009CA2330329C Cerebrospinal and vascular pharmaceutical composition and process for preparing the same
08/25/2009CA2234500C Novel biologically active silicon-based compositions
08/25/2009CA2215356C Novel embolizing compositions
08/25/2009CA2088889C Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy
08/24/2009CA2598095A1 Method of relieving or avoiding side effect of steroid
08/20/2009WO2009103069A1 Skin penetration enhancing systems for polar drugs
08/20/2009WO2009102894A2 Arginine-conjugated bioreducible poly (disulfide amine) polymers for gene delivery systems
08/20/2009WO2009102814A2 Mucosally non-irritative liquid amphotericin b formulations and methods for treating non-invasive fungus-induced mucositis
08/20/2009WO2009102375A2 Use of avicins to deliver therapeutic and diagnostic agents
08/20/2009WO2009102081A1 Cyclic single-stranded nucleic acid complex and method for producing the same
08/20/2009WO2009102038A1 Orally disintegrating tablets
08/20/2009WO2009101967A1 Phosphatidylserine complex and method for stabilization of phosphatidylserine
08/20/2009WO2009101940A1 Tablet having improved elution properties
08/20/2009WO2009101658A1 Timed-release pharmaceutical preparation
08/20/2009WO2009101657A1 Timed-release pharmaceutical preparation
08/20/2009WO2009101656A1 Delayed release preparation
08/20/2009WO2009101614A1 Casein particles encapsulating therapeutically active agents and uses thereof
08/20/2009WO2009101613A1 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
08/20/2009WO2009101412A1 Topical pharmaceutical composition
08/20/2009WO2009101320A2 Fine powder of polyamide from renewable materials and method for making such powder
08/20/2009WO2009101178A1 Enzymatic conjugation of bioactive moieties
08/20/2009WO2009100645A1 Polycationic gene carriers formed of endogenous amino group-bearing monomers
08/20/2009WO2009081283A3 Aqueous formulations of acetaminophen for injection
08/20/2009WO2008145365A3 Treatment of surfactants with cyclodextrins
08/20/2009WO2008096012A3 Multimeric conjugate
08/20/2009WO2008023277A8 Compositions containing coenzyme q-10 and dihydrolipoic acid
08/20/2009WO2007099559A9 Method of preparation for novel composition of 2-{(2,6 dichlorophenyl) amino] benzeneacetic acid carboxymethyl ester or 2-[2-[2-(2,6-dichlorophenyl) amino] phenylacetoxyacetic acid and method of its use
08/20/2009US20090209747 Method to inhibit cell growth using oligonucleotides
08/20/2009US20090209734 Peptidyl prodrugs and linkers and stabilizers useful therefor
08/20/2009US20090209664 Demulsifiers and methods for use in pharmaceutical applications
08/20/2009US20090209663 Long term weight maintenance
08/20/2009US20090209662 Isomaltulose with improved flowability
08/20/2009US20090209661 Delivery particle
08/20/2009US20090209660 Biomaterial containing degradation stabilized polymer
08/20/2009US20090209658 Embolic compositions
08/20/2009US20090209471 Abuse-resistant amphetamine prodrugs
08/20/2009US20090209465 MCT1 Transporters Expressed in Blood Brain Barrier Cells
08/20/2009US20090209037 Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/20/2009US20090208589 Novel hydrophilic polymers as medical lubricants and gels
08/20/2009US20090208584 Solid preparation
08/20/2009US20090208581 Formulations limiting spread of pulmonary infections
08/20/2009US20090208567 Substance-containing carbon nanohorn composite having polyamine plug and process for producing the same
08/20/2009US20090208552 Cross-linked fatty acid-based biomaterials
08/20/2009US20090208523 Adjuvant for vaccines
08/20/2009US20090208411 Cytotoxicity mediation of cells evidencing surface expression of CD44
08/20/2009CA2715133A1 Fine powder of polyamide from renewable materials and method for making such powder
08/20/2009CA2714585A1 Enzymatic conjugation of bioactive moieties
08/20/2009CA2714524A1 Tablet having improved elution properties
08/20/2009CA2706577A1 Use of avicins to deliver therapeutic and diagnostic agents
08/19/2009EP2090607A1 Polymeric derivative of nucleic acid metabolic antagonist
08/19/2009EP2090589A1 Albumin-fused Kunitz domain peptides
08/19/2009EP2090323A1 Protein-Proteophor Complexes
08/19/2009EP2090322A1 Use of fsh receptor ligands for diagnosis and therapy of cancer
08/19/2009EP2090314A1 Ophthalmic aqeous liquid preparation
08/19/2009EP2090310A1 Method for prevention of coloration in donepezil-containing skin adhesive preparation, and method for reducing the production of donepezil analogue in donepezil-containing skin adhesive preparation
08/19/2009EP2090305A1 Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome
08/19/2009EP2090300A1 Sustained release preparation
08/19/2009EP2090298A1 Method for production of sustained release tablet
08/19/2009EP2090296A2 Application of agent complexes composed of panthenol, glycerin, citrate and/or bisabal oil against pollen allergy
08/19/2009EP2090180A1 Sweetener containing d-psicose and foods and drinks obtained by using the same
08/19/2009EP2090177A1 Food products having enhanced cocoa polyphenol content
08/19/2009EP2090165A2 Antifungal composition with enhanced bioavailability
08/19/2009EP2089514A1 Cancerous disease modifying antibodies
08/19/2009EP2089060A1 Liquid preparation comprising a complex of pimobendan and cyclodextrin
08/19/2009EP2089052A1 Peg linker compounds and biologically active conjugates thereof
08/19/2009EP2089010A1 Rapid release mini-tablets provide analgesia in laboratory animals
08/19/2009EP2089008A2 Formulations for delivery via pressurised metered dose inhalers comprising an essential oil as suspension stabiliser
1 ... 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 ... 1712